Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become a leading focus in metabolic research. By activating two incretin pathways simultaneously, it has been studied for its ability to influence glucose regulation, insulin sensitivity, appetite signaling, and overall energy balance. Early findings suggest that this dual-action mechanism may produce stronger metabolic effects than traditional single-pathway peptides. Because of its broad activity across multiple hormonal systems, tirzepatide remains a significant subject of research in weight management and metabolic health. For research use only.